Tylenol, Kleenex, Band-Aid and more put under one roof in $48.7 billion consumer brands deal

KEY TAKEAWAYS:

Kimberly-Clark is acquiring Kenvue in a $48.7 billion cash and stock deal.

The merger creates a consumer health giant with $32 billion in annual revenue.

Kenvue shareholders will receive cash and Kimberly-Clark stock valued at $21.01 per share.

The combined company will be based in Irving, Texas, with operations at Kenvue facilities.

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.

Shareholders of Kimberly-Clark will own about 54% of the combined company. Kenvue shareholders will own about 46% in what is one of the largest corporate takeovers this year.

The combined company will have a huge stable of household brands under one roof, putting Kenvue’s Listerine mout